hFGF1<sup>ΔHBS</sup>, a variant of human fibroblast growth factor 1 with three substitutions in its heparin-binding sites, was previously shown by our group to ameliorate fatty liver. This evidence concerns the gene FGF1 and Hepatic steatosis.